LSC Webinars CELL All

  1. Global Regulatory Compliance For Aseptic Barrier Systems 6/24/2026

    Reconcile differing regulatory philosophies in sterile manufacturing. Learn to use prescriptive baselines and scientific data to achieve global compliance.

  2. Building Scalable Non-Viral Gene-Edited Cell Therapy Processes 6/24/2026

    Rahul Purohit, Ph.D., discusses the challenges and opportunities of scaling non-viral gene-edited cell therapies, with practical guidance for balancing performance, cell quality, and manufacturing readiness.

  3. Automating cell therapy manufacturing without redesigning established workflow 6/24/2026
  4. Automating Cell Therapy Manufacturing Without Redesigning Workflows 6/23/2026

    Cell therapy manufacturing teams face mounting pressure to automate without disrupting workflows. Learn how incremental automation can preserve process integrity and reduce risk.

  5. How Intensified Upstream Processing Improves Scale-Up And Tech Transfer 6/22/2026

    Intensified upstream processing can improve scalability and maintain quality. Learn how automation, PAT, and data-driven control strategies help modernize workflows and support consistent performance.

  6. Smarter DNA, Healthier Cells 6/22/2026

    Standardizing cross-functional communication and unifying data architectures streamlines technology transfer, minimizes costly manufacturing deviations, and accelerates therapeutic scale-up.

  7. Creative Chromatography Solutions For Complex Small Molecules 6/18/2026

    Chromatographic modeling enables smarter purification. Discover how digital tools, fraction mapping, and expert execution can improve yield for the most challenging small-molecule separations.

  8. Generate Stable High-Producing Clones In 14 Weeks 6/18/2026

    Rising complexity is putting pressure on cell line development. Discover a streamlined approach that enables rapid generation of stable clones with strong titers and long-term consistency.

  9. Using Residual DNA Quantification Data To De-Risk mAb Development 6/11/2026

    Residual DNA quantitation offers more than impurity measurement. When used across process steps, it helps compare purification performance, identify risks early, and ensure assays remain reliable.

  10. The AI Advantage For Regulated Manufacturing 6/10/2026

    Transitioning from paper batch records to human-centered AI optimizes pharma manufacturing. Learn to secure data, cut review times by 90%, and build a strong Return on Automation business case.